Esketamine–A quick-acting novel antidepressant without the disadvantages of ketamine
Sign Up to like & getrecommendations! Published in 2022 at "Hormone Molecular Biology and Clinical Investigation"
DOI: 10.1515/hmbci-2021-0099
Abstract: Abstract Esketamine, which is an S-enantiomer of ketamine, is better than conventional antidepressants and even better than R-ketamine. This article discusses the mechanism of action of Esketamine, how different it is from other antidepressants, its… read more here.
Keywords: quick acting; acting novel; novel antidepressant; antidepressant without ... See more keywords